| ID: 132088786 | Neanderthal introgressed variant-containing enhancer experimental_55061 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162234949..162235118) | | |
| ID: 132088785 | Neanderthal introgressed variant-containing enhancer experimental_55025 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162214112..162214281) | | |
| ID: 132088784 | Neanderthal introgressed variant-containing enhancer experimental_54994 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162184792..162184961) | | |
| ID: 126806392 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:162949234-162950433 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162092724..162093923) | | |
| ID: 122847305 | Sharpr-MPRA regulatory region 10348 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162112479..162112773) | | |
| ID: 117152611 | DPP4 -4.2 kb glucocorticoid response element [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162078687..162078798) | | |
| ID: 108175345 | GCG promoter region [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162152135..162153856) | | |
| ID: 105373724 | uncharacterized LOC105373724 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162246117..162261156) | | |
| ID: 101929532 | uncharacterized LOC101929532 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162114441..162172739) | | |
| ID: 100132597 | EIF3E pseudogene 2 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162088259..162090276) | | |
| ID: 100131604 | DPP4 divergent transcript [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162074857..162077932) | | |
| ID: 399520 | translocase of inner mitochondrial membrane 8A pseudogene 1 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162076515..162077711, complement) | DDPP, TIMM8AP | |
| ID: 2641 | glucagon [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162142882..162152247, complement) | GLP-1, GLP1, GLP2, GRPP | 138030 |
| ID: 2191 | fibroblast activation protein alpha [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (162170684..162243445, complement) | DPPIVA, FAPalpha, SIMP, FAP | 600403 |